Alamar Biosciences, Inc. (California) (ALMR)
32.74
-1.50
(-4.38%)
USD |
NASDAQ |
Aug 24, 16:00
32.74
0.00 (0.00%)
After-Hours: 20:00
Alamar Biosciences Shareholders Equity (Quarterly) : 312.86M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 312.86M |
| Date | Value |
|---|---|
| March 31, 2026 | -178.07M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| 10X Genomics, Inc. | 825.55M |
| Personalis, Inc. | 235.16M |
| Twist Bioscience Corp. | 445.74M |
| Adaptive Biotechnologies Corp. | 142.91M |
| Champions Oncology, Inc. | 3.939M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 390.98M |
| Total Liabilities (Quarterly) | 78.12M |
| Debt to Equity Ratio | 0.1643 |
| Current Ratio | 11.85 |
| Net Debt Paydown Yield | 0.83% |